Blueshift Asset Management LLC Sells 10,108 Shares of HealthEquity, Inc. $HQY

Blueshift Asset Management LLC cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 79.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,558 shares of the company’s stock after selling 10,108 shares during the quarter. Blueshift Asset Management LLC’s holdings in HealthEquity were worth $268,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Arrowstreet Capital Limited Partnership acquired a new stake in HealthEquity in the second quarter valued at approximately $4,747,000. NBW Capital LLC lifted its stake in shares of HealthEquity by 2.9% in the 2nd quarter. NBW Capital LLC now owns 53,514 shares of the company’s stock valued at $5,606,000 after acquiring an additional 1,528 shares during the last quarter. M&T Bank Corp boosted its holdings in shares of HealthEquity by 6.3% during the 2nd quarter. M&T Bank Corp now owns 33,885 shares of the company’s stock valued at $3,550,000 after acquiring an additional 2,002 shares in the last quarter. New York State Common Retirement Fund boosted its holdings in shares of HealthEquity by 39.2% during the 2nd quarter. New York State Common Retirement Fund now owns 195,041 shares of the company’s stock valued at $20,432,000 after acquiring an additional 54,886 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its position in HealthEquity by 56.2% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 1,673 shares of the company’s stock worth $175,000 after acquiring an additional 602 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have commented on HQY shares. BTIG Research reiterated a “buy” rating and issued a $130.00 target price on shares of HealthEquity in a research report on Thursday. Wall Street Zen lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research report on Thursday. KeyCorp reduced their target price on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. upped their price target on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $120.07.

HealthEquity Price Performance

HealthEquity stock opened at $95.67 on Friday. The stock’s 50 day moving average is $96.41 and its 200 day moving average is $96.87. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The firm has a market cap of $8.24 billion, a P/E ratio of 43.89, a P/E/G ratio of 1.42 and a beta of 0.18. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.95%. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction on Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president owned 79,456 shares in the company, valued at $7,477,604.16. The trade was a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 10,781 shares of company stock valued at $1,016,707 in the last three months. 1.50% of the stock is owned by insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.